Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non‐responders: Double‐blinded, randomised, controlled phase 2 trial
暂无分享,去创建一个
N. Hens | P. van Damme | P. Savelkoul | C. Kremer | A. O. Oude Lashof | Ö. Koc | G. Robaeys | F. Falkenberg | Philippe De Smedt | Jorge Almeida